نتایج جستجو برای: 153sm edtmp

تعداد نتایج: 189  

Journal: :iranian journal of nuclear medicine 2013
davood beiki peiman haddad babak fallahi arash keyvan ali gholamrezanezhad

introduction: the aim of the present study was to evaluate the efficacy and safety profile of bone palliative therapy following administration of 153sm-edtmp in patients with intractable metastatic bone pain. methods: sixteen patients (9 male, 7 female) aged 29-80 years (57.3±16.7 years) with severe metastasis-related bone pain resistant to analgesic medications were enrolled in the study. all...

Journal: :iranian journal of medical physics 0
fatemeh razghandi department of physics, school of sciences, ferdowsi university of mashhad, mashhad, iran reza izadi department of physics, school of sciences, ferdowsi university of mashhad, mashhad, iran ali mowlavi department of physics, hakim sabzevari university, sabzevar, iran international centre for theoretical physics, associate and federation schemes, medical physics field, trieste, italy

introduction one of the important applications of nuclear physics in medicine is the use of radioactive elements as radiopharmaceuticals. metastatic bone disease is the most common form of malignant bone tumors. samarium-153-ethylene diamine tetramethylene phosphonate (153sm-edtmp) as a radiopharmaceutical is used for pain palliation. this radiopharmaceutical usually emits beta particles, which...

Journal: :iranian journal of nuclear medicine 0
hassan ranjbar radiopharmaceutical research and development lab (rrdl), nuclear science and technology research institute (nstri), p.o. box 14395-836, tehran, iran ali bahrami-samani radiopharmaceutical research and development lab (rrdl), nuclear science and technology research institute (nstri), p.o. box 14395-836, tehran, iran davood beiki research center for nuclear medicine, tehran university of medical sciences, tehran, iran mohammad ghannadi-maragheh radiopharmaceutical research and development lab (rrdl), nuclear science and technology research institute (nstri), p.o. box 14395-836, tehran, iran

introduction:targeted radionuclide therapy (trt) has been demonstrated to be an effective therapeutic tool in patients with disseminated bone metastasis. trt is generally performed with a single radionuclide. in this study we investigated the feasibility of combined trt with a high-energy beta emitter (153sm) and a low energy beta emitter (177lu) in wistar rats. methods: the cocktail complex of...

Journal: :asia oceania journal of nuclear medicine and biology 0
narjess ayati nuclear medicine research center, mashhad university of medical science, faculty of medicine, mashhad, iran kamran aryana nuclear medicine research center, mashhad university of medical science, faculty of medicine, mashhad, iran amir jalilian radiopharmaceutical research & development laboratory (rrdl), nuclear science and technology research institute (nstri), tehran, iran toktam hoseinnejad nuclear medicine research center, mashhad university of medical science, faculty of medicine, mashhad, iran ali bahrami samani radiopharmaceutical research & development laboratory (rrdl), nuclear science and technology research institute (nstri), tehran, iran zahra ayati school of pharmacy, mashhad university of medical science, mashhad, iran

introduction: involvement of the skeleton can cause an excruciating pain in two-thirds of terminal patients with a history of malignancy. due to several limitations of other therapies, such as analgesics, bisphosphonates, chemotherapy, hormonal therapy and external beam radiotherapy; bone-seeking radiopharmaceuticals have an important role in palliation of pain from bone metastases. although th...

2007
N ina Ottesen

Fifteen dogs were referred because of a spontaneous bone tumor, lameness, and local pain. The osteosarcoma diagnosis was established by clinical examination, X-ray, bone scintigraphy, and histological examination of biopsy material. The tumors were located in the extremities (n = 12), scapula (n = 1), maxilla (n = 1), and the frontal bone (n = 1). The dogs were given one to four i.v. injections...

Ali Mowlavi, Fatemeh Razghandi Reza Izadi,

Introduction One of the important applications of nuclear physics in medicine is the use of radioactive elements as radiopharmaceuticals. Metastatic bone disease is the most common form of malignant bone tumors. Samarium-153-ethylene diamine tetramethylene phosphonate (153Sm-EDTMP) as a radiopharmaceutical is used for pain palliation. This radiopharmaceutical usually emits beta particles, which...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990
J C Lattimer L A Corwin J Stapleton W A Volkert G J Ehrhardt A R Ketring S K Anderson J Simon W F Goeckeler

Forty dogs with spontaneous skeletal neoplasia were treated with 153Sm-EDTMP (ethylenediaminetetramethylene phosphonic acid). Both primary and metastatic lesions were treated. Two treatment regimes, a single (37 MBq (1.0 mCi)/kg dose or two 37 MBq (1.0 mCi)/kg doses separated by 1 wk) were tested. Response to treatment was varied. Large lesions with minimal tumor bone formation responded poorly...

2013
Narjess Ayati Kamran Aryana Amir Jalilian Toktam Hoseinnejad Ali Bahrami Samani Zahra Ayati Farzane Shariati S. Rasoul Zakavi

INTRODUCTION Involvement of the skeleton can cause an excruciating pain in two-thirds of terminal patients with a history of malignancy. Due to several limitations of other therapies, such as analgesics, bisphosphonates, chemotherapy, hormonal therapy and external beam radiotherapy; bone-seeking radiopharmaceuticals have an important role in palliation of pain from bone metastases. Although the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید